Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 50

1.

Milk's Role as an Epigenetic Regulator in Health and Disease.

Melnik BC, Schmitz G.

Diseases. 2017 Mar 15;5(1). pii: E12. doi: 10.3390/diseases5010012. Review.

2.

p53: key conductor of all anti-acne therapies.

Melnik BC.

J Transl Med. 2017 Sep 19;15(1):195. doi: 10.1186/s12967-017-1297-2. Review.

3.

Over-expression of p53 explains isotretinoin's teratogenicity.

Melnik BC.

Exp Dermatol. 2017 Aug 20. doi: 10.1111/exd.13420. [Epub ahead of print]

PMID:
28833556
4.

Milk disrupts p53 and DNMT1, the guardians of the genome: implications for acne vulgaris and prostate cancer.

Melnik BC.

Nutr Metab (Lond). 2017 Aug 15;14:55. doi: 10.1186/s12986-017-0212-4. eCollection 2017.

5.

Olumacostat Glasaretil, a Promising Topical Sebum-Suppressing Agent that Affects All Major Pathogenic Factors of Acne Vulgaris.

Melnik BC.

J Invest Dermatol. 2017 Jul;137(7):1405-1408. doi: 10.1016/j.jid.2017.01.026. Review.

PMID:
28647025
6.

Apoptosis May Explain the Pharmacological Mode of Action and Adverse Effects of Isotretinoin, Including Teratogenicity.

Melnik BC.

Acta Derm Venereol. 2017 Feb 8;97(2):173-181. doi: 10.2340/00015555-2535. Review.

7.

The TRAIL to acne pathogenesis: let's focus on death pathways.

Melnik BC.

Exp Dermatol. 2017 Mar;26(3):270-272. doi: 10.1111/exd.13169. Epub 2016 Dec 9.

PMID:
27541445
8.

Milk: An epigenetic inducer of FoxP3 expression.

Melnik BC, John SM, Schmitz G.

J Allergy Clin Immunol. 2016 Sep;138(3):937-938. doi: 10.1016/j.jaci.2016.04.039. Epub 2016 Jul 12. No abstract available.

PMID:
27417024
9.

Milk miRNAs: simple nutrients or systemic functional regulators?

Melnik BC, Kakulas F, Geddes DT, Hartmann PE, John SM, Carrera-Bastos P, Cordain L, Schmitz G.

Nutr Metab (Lond). 2016 Jun 21;13:42. doi: 10.1186/s12986-016-0101-2. eCollection 2016.

10.

Milk: a postnatal imprinting system stabilizing FoxP3 expression and regulatory T cell differentiation.

Melnik BC, John SM, Carrera-Bastos P, Schmitz G.

Clin Transl Allergy. 2016 May 12;6:18. doi: 10.1186/s13601-016-0108-9. eCollection 2016. Review.

11.

Pro-inflammatory sebocyte growth and survival signalling in acne vulgaris are reversed by pro-apoptotic isotretinoin signalling.

Melnik BC.

Exp Dermatol. 2016 Sep;25(9):676-7. doi: 10.1111/exd.13032. No abstract available.

PMID:
27095186
12.

Milk: an epigenetic amplifier of FTO-mediated transcription? Implications for Western diseases.

Melnik BC.

J Transl Med. 2015 Dec 21;13:385. doi: 10.1186/s12967-015-0746-z. Review.

13.

Is sebocyte-derived leptin the missing link between hyperseborrhea, ductal hypoxia, inflammation and comedogenesis in acne vulgaris?

Melnik BC.

Exp Dermatol. 2016 Mar;25(3):181-2. doi: 10.1111/exd.12917. Epub 2016 Feb 10. No abstract available.

PMID:
26660941
14.

Western diet-induced imbalances of FoxO1 and mTORC1 signalling promote the sebofollicular inflammasomopathy acne vulgaris.

Melnik BC.

Exp Dermatol. 2016 Feb;25(2):103-4. doi: 10.1111/exd.12898. Epub 2016 Jan 12. No abstract available.

PMID:
26567085
15.

Rosacea: The Blessing of the Celts - An Approach to Pathogenesis Through Translational Research.

Melnik BC.

Acta Derm Venereol. 2016 Feb;96(2):147-56. doi: 10.2340/00015555-2220. Review.

16.

Milk--A Nutrient System of Mammalian Evolution Promoting mTORC1-Dependent Translation.

Melnik BC.

Int J Mol Sci. 2015 Jul 27;16(8):17048-87. doi: 10.3390/ijms160817048. Review.

17.

Linking diet to acne metabolomics, inflammation, and comedogenesis: an update.

Melnik BC.

Clin Cosmet Investig Dermatol. 2015 Jul 15;8:371-88. doi: 10.2147/CCID.S69135. eCollection 2015. Review.

18.

MiR-21: an environmental driver of malignant melanoma?

Melnik BC.

J Transl Med. 2015 Jun 27;13:202. doi: 10.1186/s12967-015-0570-5. Review.

19.

Milk consumption during pregnancy increases birth weight, a risk factor for the development of diseases of civilization.

Melnik BC, John SM, Schmitz G.

J Transl Med. 2015 Jan 16;13:13. doi: 10.1186/s12967-014-0377-9. Review.

Supplemental Content

Loading ...
Support Center